CA2693090A1 - Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal - Google Patents

Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal Download PDF

Info

Publication number
CA2693090A1
CA2693090A1 CA2693090A CA2693090A CA2693090A1 CA 2693090 A1 CA2693090 A1 CA 2693090A1 CA 2693090 A CA2693090 A CA 2693090A CA 2693090 A CA2693090 A CA 2693090A CA 2693090 A1 CA2693090 A1 CA 2693090A1
Authority
CA
Canada
Prior art keywords
tumor
protein
marker
colorectal cancer
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2693090A
Other languages
English (en)
French (fr)
Inventor
Jean-Philippe Charrier
Genevieve Choquet-Kastylevsky
Dominique Rolland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2693090A1 publication Critical patent/CA2693090A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
CA2693090A 2007-07-19 2008-07-10 Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal Abandoned CA2693090A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0705201A FR2919062B1 (fr) 2007-07-19 2007-07-19 Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
FR0705201 2007-07-19
PCT/FR2008/051290 WO2009019366A2 (fr) 2007-07-19 2008-07-10 Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal

Publications (1)

Publication Number Publication Date
CA2693090A1 true CA2693090A1 (fr) 2009-02-12

Family

ID=38912485

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2693090A Abandoned CA2693090A1 (fr) 2007-07-19 2008-07-10 Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal

Country Status (9)

Country Link
US (1) US8367362B2 (ja)
EP (1) EP2167970B1 (ja)
JP (1) JP5559050B2 (ja)
CN (1) CN102124343B (ja)
AU (1) AU2008285555B2 (ja)
CA (1) CA2693090A1 (ja)
ES (1) ES2570609T3 (ja)
FR (1) FR2919062B1 (ja)
WO (1) WO2009019366A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102565267B (zh) * 2012-01-06 2014-12-10 北京师范大学 筛查结直肠癌的试剂盒
CN102662012B (zh) * 2012-05-08 2014-06-11 北京师范大学 筛查结直肠腺瘤的试剂盒
FR3001805B1 (fr) 2013-02-01 2015-02-20 Biomerieux Sa Procede de detection d'un cancer colorectal
EP3466975A1 (en) * 2017-10-05 2019-04-10 Laboratoire Français du Fractionnement et des Biotechnologies A specific binding molecule directed against galectin-3 protein
US20210214797A1 (en) * 2018-06-01 2021-07-15 Geneoscopy, Llc Detection method

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920484A1 (de) 1979-05-21 1980-12-04 Bosch Gmbh Robert Messeinrichtung mit magnetischem kreis zum messen eines gleichstroms
US4529931A (en) * 1983-04-07 1985-07-16 Ford Motor Company Single-coil current measuring circuit
FR2581456B1 (fr) 1985-05-02 1987-07-17 Pasteur Institut Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
US5360715A (en) * 1988-06-07 1994-11-01 California Institute Of Technology Plastin isoforms and their uses
US5002870A (en) * 1988-06-07 1991-03-26 California Institute For Medical Research Plastin isoforms and their use
JP2816175B2 (ja) 1989-04-28 1998-10-27 三菱電機株式会社 直流電流測定装置
US5223789A (en) * 1989-06-23 1993-06-29 Fuji Electric Co., Ltd. AC/DC current detecting method
JPH0464068A (ja) 1990-07-02 1992-02-28 Fuji Electric Co Ltd 直流電流検出方法
CA2054149A1 (en) 1990-10-29 1992-04-30 Eric Pringault Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals
JP2892171B2 (ja) * 1991-03-22 1999-05-17 寳酒造株式会社 ポリペプチド
US6291205B1 (en) * 1992-06-12 2001-09-18 Merck & Co., Inc. Method of increasing production of disulfide bonded recombinant proteins by saccharomyces cerevisiae
US6001632A (en) * 1996-05-15 1999-12-14 Incyte Pharmaceuticals, Inc. Human protein disulfide isomerase
DE19642472A1 (de) 1996-10-15 1998-04-16 Abb Research Ltd Flußkompensierter Stromsensor
EP1135686B1 (en) 1998-12-01 2006-11-22 WRAIR (Walter Reed Army Institute of Research) Diagnosis of stage or aggressiveness of cancer
EP1155126A2 (en) 1999-02-22 2001-11-21 Incyte Pharmaceuticals, Inc. Genes associated with diseases of the colon
WO2000062070A2 (en) * 1999-04-09 2000-10-19 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
CA2384713A1 (en) * 1999-09-29 2001-04-05 Human Genome Sciences, Inc. Colon and colon cancer associated polynucleotides and polypeptides
AU2001289864A1 (en) 2000-09-08 2002-03-22 Bayer Aktiengesellschaft Regulation of human protein disulfide isomerase-like enzyme
US20040110668A1 (en) * 2000-10-02 2004-06-10 Burgess Christopher C. Nucleic acid sequences differentially expressed in cancer tissue
US20020160382A1 (en) * 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
US7691567B2 (en) * 2000-10-30 2010-04-06 Board Of Regents, The University Of Texas System Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
US20030082533A1 (en) * 2001-01-26 2003-05-01 Henry Yue Intelectin
US20030087818A1 (en) * 2001-02-02 2003-05-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
GB0208331D0 (en) 2002-04-11 2002-05-22 Oxford Glycosciences Uk Ltd Proteins
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Ｔｉｍｐ１を用いた検出方法
KR100595364B1 (ko) 2003-02-20 2006-07-03 재단법인 목암생명공학연구소 Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
US20040191782A1 (en) * 2003-03-31 2004-09-30 Yixin Wang Colorectal cancer prognostics
WO2005015218A1 (en) 2003-07-21 2005-02-17 Roche Diagnostics Gmbh Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer
WO2005015219A1 (en) * 2003-07-21 2005-02-17 Roche Diagnostics Gmbh Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as marker for colorectal cancer
WO2005015226A1 (en) 2003-08-08 2005-02-17 Roche Diagnostics Gmbh Use of protein t-plastin (plst) as a marker for colorectal cancer
EP2026071B1 (en) 2004-02-19 2013-07-31 Yale University Identification of cancer protein biomarkers using proteomic techniques
EP1766091A4 (en) * 2004-05-27 2009-03-18 Vertex Pharma BIOMARKER FOR MONITORING THE INHIBITION OF THE IMPDH PATH
CA2569079A1 (en) * 2004-06-03 2005-12-15 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US20090297523A1 (en) 2004-07-27 2009-12-03 Yale University Erm family binding agents and their use in diagnosis and treatment of proliferative conditions
AT500719B1 (de) 2004-09-08 2010-06-15 Red Bull Gmbh Chaperone als tumormarker
JP2008527351A (ja) 2005-01-06 2008-07-24 イースタン バージニア メディカル スクール 前立腺癌のバイオマーカーとしてのアポリポタンパク質ａ−ｉｉアイソフォーム
US20060192550A1 (en) 2005-02-25 2006-08-31 Sandquist David A Current sensor with magnetic toroid single frequency detection scheme
EP1724586A3 (en) * 2005-05-21 2007-07-04 ProteoSys AG Annexin for cancer risk assessment
JP2008547028A (ja) 2005-06-24 2008-12-25 サイファージェン バイオシステムズ， インコーポレイテッド 卵巣癌用のバイオマーカー
EP2166357A1 (en) 2005-08-18 2010-03-24 Zadec Aps Protein marker for diagnosing colorectal cancer
EP1775590A1 (en) * 2005-10-11 2007-04-18 Laboratorios S.A.L.V.A.T., S.A. Non-invasive in vitro method to detect transitional cell carcinoma of the bladder
CN1967246A (zh) * 2005-11-18 2007-05-23 上海中科新生命生物科技有限公司 酰化氨基酸水解酶1及其抗体检测肝癌的应用
EP2537525A1 (en) 2005-12-16 2012-12-26 Electrophoretics Limited Diagnosis and prognosis of colorectal cancer
WO2007140352A2 (en) 2006-05-26 2007-12-06 Invitrogen Corporation Plasma membrane and secreted cancer biomarkers
EP2057465A4 (en) 2006-08-09 2010-04-21 Homestead Clinical Corp SPECIFIC ORGAN PROTEINS AND METHODS OF USE
JP2010502970A (ja) 2006-09-08 2010-01-28 アンスティテュ・グスターブ・ルシ カルレティキュリン、ＫＤＥＬ受容体および／またはＥＲｐ５７の細胞表面露出を調節する化合物および癌の処置の効率を評価するためのその使用
CA2665090A1 (en) 2006-09-22 2008-03-27 Dana-Farber Cancer Institute, Inc. Methods for treating mica-related disorders
FR2919065B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
ES2565512T3 (es) * 2007-07-19 2016-04-05 bioMérieux Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919064B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
FR2919061B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal.
FR2919060B1 (fr) * 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
FR2933773B1 (fr) * 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal

Also Published As

Publication number Publication date
US20100129844A1 (en) 2010-05-27
AU2008285555B2 (en) 2014-08-14
FR2919062B1 (fr) 2009-10-02
JP5559050B2 (ja) 2014-07-23
EP2167970B1 (fr) 2016-02-17
CN102124343B (zh) 2014-07-02
ES2570609T3 (es) 2016-05-19
US8367362B2 (en) 2013-02-05
JP2010533850A (ja) 2010-10-28
FR2919062A1 (fr) 2009-01-23
WO2009019366A3 (fr) 2009-05-07
WO2009019366A2 (fr) 2009-02-12
AU2008285555A1 (en) 2009-02-12
CN102124343A (zh) 2011-07-13
EP2167970A2 (fr) 2010-03-31

Similar Documents

Publication Publication Date Title
EP2171469B1 (fr) Procede in vitro de dosage du leucocyte elastase inhibitor pour le diagnostic du cancer colorectal
CA2693098C (fr) Procede de dosage de la proteine de liaison hepatique aux acides gras, de l'antigene carcino-embryonnaire, et de l'antigene carbohydrate 19-9 pour le diagnostic in vitro du cancercolorectal
EP2294421B1 (fr) Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal
EP2171468B1 (fr) Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
EP2167972B1 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
EP2443152B1 (fr) Procédé de dosage de la prodéfensine-a6 pour le diagnostic in vitro du cancer colorectal
EP2167971B1 (fr) Procede de dosage in vitro de l'ezrine pour le diagnostic du cancer colorectal
CA2695191C (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal
EP2167970B1 (fr) Procede de dosage in vitro de l'aminoacylase 1 pour le diagnostic du cancer colorectal

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130531

FZDE Dead

Effective date: 20200923